| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |